Yael Margolin
Directeur/Membre du Conseil chez SCINAI IMMUNOTHERAPEUTICS LTD.
Fortune : 926 $ au 30/06/2024
Profil
Yael Margolin is currently the Director at Ramot at Tel Aviv University Ltd., Independent External Director at Scinai Immunotherapeutics Ltd., Independent Director at Purple Biotech Ltd., Director at Tau Ventures Ltd., President at Gamida Cell, Inc., and Advisory Board Member at Welltech Ventures.
Previously, Dr. Margolin held positions as President & Director at Gamida Cell Ltd., Director at Collgard Biopharmaceuticals Ltd., Independent Director at POINT Biopharma Global, Inc., Director at Quris Technologies Ltd., Director at Makesense Digital Health Ltd., Program Manager at Teva Pharmaceuticals USA, Inc., Vice President at Denali Ventures LLC, and Associate at Yale School of Medicine.
Dr. Margolin received undergraduate and graduate degrees from Tel-Aviv University and a doctorate degree from the Weizmann Institute of Science.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/04/2024 | 133 200 ( 0,02% ) | 926 $ | 30/06/2024 |
Postes actifs de Yael Margolin
| Sociétés | Poste | Début |
|---|---|---|
| SCINAI IMMUNOTHERAPEUTICS LTD. | Directeur/Membre du Conseil | 01/01/2019 |
| PURPLE BIOTECH LTD | Directeur/Membre du Conseil | 20/12/2023 |
Ramot at Tel Aviv University Ltd.
 Ramot at Tel Aviv University Ltd. Miscellaneous Commercial ServicesCommercial Services Ramot at Tel Aviv University Ltd. operates as a technology transfer company of Tel Aviv University (TAU). It provides legal and commercial frameworks for inventions made by TAU faculty, students, and researchers. The firm licenses the university's intellectual property to third parties through agreements; facilitates collaborative research partnerships between business partners and TAU researchers; establishes a company; and forms joint ventures that promote TAU technologies. The company was founded in 1973 and is headquartered in Tel Aviv, Israel. | Directeur/Membre du Conseil | 01/01/2020 |
Gamida Cell, Inc.
 Gamida Cell, Inc. BiotechnologyHealth Technology Part of Gamida Cell Ltd., Gamida Cell, Inc. develops cellular and immune therapeutics. The company is based in Medfield, MA. The CEO of the company is Julian Adams. | President | - |
Tau Ventures Ltd.
 Tau Ventures Ltd. Investment ManagersFinance TAU Ventures Ltd (TAU Ventures) is a venture capital subsidiary of Tel-Aviv University founded in 2017 by Behzad Kianmahd. The firm is headquartered in Tel Aviv, Israel. | Directeur/Membre du Conseil | - |
Welltech Ventures
 Welltech Ventures Investment ManagersFinance Welltech Ventures is a venture capital firm founded in 2019 by Galit Horovitz and Amir Alroy. The firm is headquartered in Tel Aviv, Israel. | Consultant / Advisor | - |
Anciens postes connus de Yael Margolin
| Sociétés | Poste | Fin |
|---|---|---|
| POIT BIOP | Directeur/Membre du Conseil | 27/12/2023 |
| GAMIDA CELL LTD. | Directeur Général | 20/11/2017 |
Teva Pharmaceuticals USA, Inc.
 Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Corporate Officer/Principal | 01/01/1998 |
| ░░░░ ░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Yael Margolin
| Tel-Aviv University | Graduate Degree |
| Weizmann Institute of Science | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| GAMIDA CELL LTD. | Health Technology |
| SCINAI IMMUNOTHERAPEUTICS LTD. | Health Technology |
| PURPLE BIOTECH LTD | Health Technology |
| POIT BIOP | Health Technology |
| Entreprise privées | 9 |
|---|---|
Ramot at Tel Aviv University Ltd.
Ramot at Tel Aviv University Ltd. Miscellaneous Commercial ServicesCommercial Services Ramot at Tel Aviv University Ltd. operates as a technology transfer company of Tel Aviv University (TAU). It provides legal and commercial frameworks for inventions made by TAU faculty, students, and researchers. The firm licenses the university's intellectual property to third parties through agreements; facilitates collaborative research partnerships between business partners and TAU researchers; establishes a company; and forms joint ventures that promote TAU technologies. The company was founded in 1973 and is headquartered in Tel Aviv, Israel. | Commercial Services |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Health Technology |
Denali Ventures LLC
 Denali Ventures LLC Investment ManagersFinance Denali Ventures LLC (Denali) was a private Israeli venture capital firm which was founded in 1998 with the backing of private US investors, and ceased operating in 2008. Denali focused exclusively on investments in life science and health care technology companies. Located in Herzlia, the firm invested in Israel while sueing a global approach towards product and corporate development. | Finance |
Collgard Biopharmaceuticals Ltd.
 Collgard Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Collgard Biopharmaceuticals, the tissue therapeutics company, is developing drug treatments that target disease progression by directly influencing the tissue regeneration process. Central to Collgard's novel approach is its lead drug candidate, Tempostatin (Halofuginone hydrobromide). Tempostatin is a multi-indication, small-molecule drug candidate that has been identified by the company as influencing a 'master switch' in the body's tissue repair process. As a potent and selective regulator of stromal cell activation, cell migration and excessive collagen type I synthesis, Tempostatin makes it possible to harness and direct the tissue repair process for treating diseases acting at the tissue level. Collgard is developing therapeutic solutions for several clinical indications with significant unmet clinical needs. These solutions are based on highly specific control of the tissue repair process. Current programs target the following indications vascular restenosis, end-organ fibrosis, selected cancers and dermal fibroproliferative disorders. Tempostatin holds exceptional promise based on addressing a fundamental underlying pathological process that is not accessible to other current therapeutic approaches. In developing Tempostatin, Collgard seeks to offer novel therapeutic solutions as well as extend the effectiveness of existing therapies. Founded in 1996, Collgard Biopharmaceuticals is a privately held, clinical stage company, led by a global team of medical and drug development experts based in Atlanta and Tel Aviv. Scientific and clinical collaborators include The Mayo Clinic, the U.S. NCI, the EORTC, and Harvard Medical School. Collgard was founded by Medica Venture Partners. Additional investors include Mayo Medical Ventures, Denali Ventures, Yozma Group, and Comsor. | Health Technology |
Tau Ventures Ltd.
Tau Ventures Ltd. Investment ManagersFinance TAU Ventures Ltd (TAU Ventures) is a venture capital subsidiary of Tel-Aviv University founded in 2017 by Behzad Kianmahd. The firm is headquartered in Tel Aviv, Israel. | Finance |
Gamida Cell, Inc.
Gamida Cell, Inc. BiotechnologyHealth Technology Part of Gamida Cell Ltd., Gamida Cell, Inc. develops cellular and immune therapeutics. The company is based in Medfield, MA. The CEO of the company is Julian Adams. | Health Technology |
Welltech Ventures
Welltech Ventures Investment ManagersFinance Welltech Ventures is a venture capital firm founded in 2019 by Galit Horovitz and Amir Alroy. The firm is headquartered in Tel Aviv, Israel. | Finance |
Makesense Digital Health Ltd.
 Makesense Digital Health Ltd. Packaged SoftwareTechnology Services MakeSense Digital Health Ltd was founded by Alex Tolmach and Lior Eshel, with Lior Eshel serving as CEO since incorporation. The Israeli company develops an AI-based nutritional monitoring technology that allows users to measure the nutritional value of their meals without the need for manual meal-logging in a food diary. | Technology Services |
Quris Technologies Ltd.
 Quris Technologies Ltd. Packaged SoftwareTechnology Services Quris Technologies Ltd. is a company based in Tel Aviv, Israel that is revolutionizing the drug development process by pioneering clinical trials on chips. The Israeli company tests thousands of novel drug candidates on hundreds of miniaturized "patients-on-a-chip" using their fully automated, self-training AI platform. This platform accurately predicts clinical safety and efficacy for novel drugs faster and more cost-effectively than ever before, all while minimizing animal testing. The company was founded by Isaac Bentwich and Yossi Haran, and Isaac Bentwich has been the CEO since incorporation. | Technology Services |
